Search

everythinglearnresearchcommunity

for

Search:↓

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

More effective methods are needed to prevent hair loss from chemotherapy.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

New cancer treatments aim to reduce side effects and improve effectiveness.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Safflower extract helps protect hair follicle cells from damage caused by chemotherapy.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

The treatments for fungal nail infection, hair loss in men, benign nail tumor, and chemotherapy-associated nail bed inflammation are effective and safe.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

New alopecia treatments aim for better results and fewer side effects.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.